Explore the full insider trade history of INC Research Holdings, Inc., a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was reported on 5 February 2016 (Cession). Among the most active insiders: Macdonald Alistair. The full history is free.
43
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
28 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate INC Research Holdings, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,788 of 24,985 companies
40.5
score / 100
Value
58
Quality
23
FCF yld-4.9%
Earn yld13%
EV/EBITDA·
ROE-28%
Gross mgn7.5%
Net mgn4.9%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1,200 sharesClass A Common StockSEC:0001624044-16-000006:6
25 of 43 declarations
About INC Research Holdings, Inc.
INC Research Holdings, Inc. is a clinical research organization that provides drug development services to pharmaceutical and biopharmaceutical companies. It focuses on optimizing research processes to enhance the efficiency of clinical trials.